|
Investing in Medical Nanotechnologies II, Conference and Exhibition 2007
Building on the success of Investing in Medical Nanotechnologies I, this event promises a display of state-of-the-art medical nanotechnologies and routes to finance. The associated exhibition will showcase cutting edge nanotechnologies in clinical applications. The event will provide a platform for new companies trying to commercialize nano and micro technologies to get in front of investors. The investors and business support organisations will be able to identify the key technologies of future as well as new customers.
Be
first to learn the technology trends and market opportunities
in nanomedicine.
- Learn from top industrial leaders on how nanotech drives new technology applications in medicine.
- Hear from VCs about the best investing strategies and overcoming challenges.
- Find out about new technologies for medical applications.
- Hear from clinicians on how nanotechnology enables new diagnostics and therapeutic techniques.
- Participate in discussions with experts in the field.
- Meet exhibitors at the cutting edge of medical nanotechnology
Speakers include:
|
|
|
Dr Thomas Keller, Director - Worldwide Applied Technology, GlaxoSmithKline
|
Prof. Jörg Vienken, Vice-President BioScience Department, Fresenius Medical Care
|
Prof. Dr. J.W. Hans Hofstraat, Vice President, Healthcare Strategic Partnerships, Philips Research
|
|
|
|
Dr. Renzo Tomellini, Head of Nanotechnology Unit, European Commission |
Prof. Clive Washington, Principal Scientist, Astra Zeneca |
Dr Tar Choon Aw, Prof. of Chemical Pathology, Monash University School of Medicine, Malaysia |
Companies attending include:
Philips Research
GlaxoSmithKline
Fresenius Medical Care
European Commission
Astra Zeneca
Volcano Corporation
Medpole SA
Magnecell Ltd
Oxford Biomaterials
Signifix
ImuThes
STMicroelectronics
Farfield Scientific
EminateMTI Partners Ltd
The University of Manchester-Intellectual Property Ltd
Consorzio Proplast
The London Centre for Nanotechnology
Institute of Nanotechnology
Leeds Medical School
NMI Natural and Medical Sciences Institute
Mölnlycke Health Care
Xiros plc
Loughborough Innovation Centre
MTI Partners Ltd.
Leeds Medical School
F J Cleveland
Renami, Brazil
Monash University School of Medicine, Malaysia
University of Delhi,India
Tehran Medical University, Iran
|
The Wellcome Trust
GE Healthcare
Johnson & Johnson
EMEA
Olympus UK Ltd
University of Lund
Oxford Nanolabs
National Institute for Public Health and the Environment (RIVM),Netherlands
Research Center for Science and Technology in Medicine
ATP Consulting Ltd
Szczecin University of Technology
Instytut Wysokich Cisnien
Exilica Limited
CEMMNT Hub Ltd
Bio Nano Centre, London
Oxfordshire Bioscience Network
PlasmaChem
CSIRO Molecular and Health Technologies
Medical Innovation Forum
Rutherford Appleton Laboratory
University College London
Loughborough University
Technical University of Denmark Agri-Food and Biosciences Institute Yonsei University, South Korea
Institute of Textiles and Clothing, The Hong Kong Polytechnic University, China
Bharathidasan Institute of Technology,India
|
Sponsored by:
|
tiny
technology. BIG OPPORTUNITIES
tinytechjobs is a unique global career web site
focused on jobs in nanotechnology, microtechnology,
and information technology. It allows job seekers
to search through a large database of industry jobs
and apply online and it offers job postings, resume
database search, and effective targeted advertising
opportunities to employers. tinytechjobs also powers
the career sections of a number of portal websites
dedicated to nanotechnology and microtechnology.
These 20 partner sites include SmallTimes, ASME
Nanotechnology Institute, the Canadian Nanobusiness
Alliance, and the European Nanobusiness Association.
The site also contains many resources for those
interested in nanotechnology, including education
and research information and links, company information,
a calendar of industry events, and links to journals,
associations, and societies.
http://www.tinytechjobs.com
|
 | . MTI is one of the UK’s leading providers of venture capital to technology companies that are at an early stage in their development or recovery supported from its offices in London and Boston. MTI's strength lies in its appreciation of technology companies, coupled with the technical and commercial experience of its executives who have a passion for helping young companies evolve and grow. MTI's overriding motivation for investment is a company's potential for commercial success, determined by the quality of its technology, potential market, and the calibre of its management. Recent example investments include ApaTech and Powerlase and recent realisations include Chevin (ASG Inc), Screen Technology (AIM) and Eleksen (AIM).
|
|
